ClinicalTrials.govpublic full text
Axitinib and Nivolumab for the Treatment of Mucosal Melanoma
mucosal melanoma, axitinib, nivolumab, pd-1 blockade, stereotactic body radiotherapy, ipilimumab, 22-017, head/neck, sinonasal, oral cavity, conjunctival, gastrointestinal
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 893114
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.